Stockscreener 앱 받기
25.18
0.18%
-0.045
전일 마감가:
$25.23
열려 있는:
$25.18
하루 거래량:
1,064
Relative Volume:
0.11
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.10%
1개월 성능:
-0.22%
6개월 성능:
-0.92%
1년 성능:
+0.00%
1일 변동 폭
$25.18
$25.18
1주일 범위
$25.16
$25.23
52주 변동 폭
$24.96
$25.54
Shl Telemedicine Ltd Performanc Stock (STBF) Company Profile
STBF을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STBF
Shl Telemedicine Ltd Performanc
|
25.18 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
295.12 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
599.14 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
602.00 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
232.89 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
529.92 | 124.43B | 0 | 0 | 0 | 0.00 |
Shl Telemedicine Ltd Performanc 주식(STBF)의 최신 뉴스
Take Care Before Jumping Onto SHL Telemedicine Ltd. (VTX:SHLTN) Even Though It's 26% Cheaper - Simply Wall St
DocGo and SHL Telemedicine Partner to Revolutionize Patient Access to Cardiovascular Care - Business Wire
SHL Telemedicine (NASDAQ:SHLT) Shares Up 23.7%What's Next? - MarketBeat
Y.D. More Investments Ltd Reduces Stake in SHL Telemedicine Ltd - GuruFocus.com
SHL Telemedicine to Appoint David Arnon as CEO of SHL Telemedicine - Business Wire
SHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli Activity - Business Wire
SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test - Business Wire
SHL Telemedicine Announces Official Launch of SmartHeart - Business Wire
SHL Announces Full-Year 2023 ResultsStable Revenue Growth Alongside Groundbreaking Clinical Milestones - Business Wire
Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient Care - Business Wire
SHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment - Business Wire
SHL Telemedicine: Invitation to Conference Call Presenting Annual Results 2023 - Business Wire
SHL Telemedicine Receives Buy Rating with $11.00 Price Target - Business Wire
Imperial College London TELE-ACS Clinical Trial Results, Using SHL Telemedicine’s SmartHeart® Technology, to Be Presented at ACC 24 - Business Wire
SHL Telemedicine Introduces SmartHeart® Direct-to-Consumer Membership Plan in the US - Business Wire
SHL Telemedicine Establishes US Nationwide Cardiology Network for ECG Interpretations and Telehealth Visits - Business Wire
SHL Telemedicine Announces Advancements in its Direct-to-Consumer Strategy in the US - Business Wire
SHL Announces Half-Year Results 2023 – Strategic Moves to Accelerate Growth - Business Wire
SHL Telemedicine to Commence Trading on NASDAQ Under the Symbol "SHLT" - PR Newswire
Shl Telemedicine Ltd Performanc (STBF) 재무 분석
Shl Telemedicine Ltd Performanc (STBF)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.99%
자본화:
|
볼륨(24시간):